Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AbbVie Inc. | 83,171 | reported | 27 Feb 2026 | tx 80+810,201−530,579 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Feb 2026 | TAX_WITHHOLDING | AbbVie Inc. | 23,812 | 232.08 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 9,266 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 9,432 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 8,988 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 26,063 | 0.00 USD | |
| 18 Feb 2026 | GRANT_AWARD | AbbVie Inc. | 26,812 | 0.00 USD | deriv |
| 31 Mar 2025 | EXERCISE | AbbVie Inc. | 25,700 | 79.02 USD | |
| 31 Mar 2025 | SALE | AbbVie Inc. | 33,132 | 210.54 USD | |
| 31 Mar 2025 | SALE | AbbVie Inc. | 25,700 | 209.49 USD | |
| 31 Mar 2025 | EXERCISE | AbbVie Inc. | 25,700 | 79.02 USD | deriv |
| 28 Feb 2025 | TAX_WITHHOLDING | AbbVie Inc. | 20,226 | 205.02 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 7,840 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 19,111 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 9,432 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 9,268 | 0.00 USD | |
| 13 Feb 2025 | GRANT_AWARD | AbbVie Inc. | 33,854 | 0.00 USD | deriv |
| 18 Mar 2024 | EXERCISE | AbbVie Inc. | 26,110 | 61.36 USD | |
| 18 Mar 2024 | SALE | AbbVie Inc. | 27,740 | 178.69 USD | |
| 18 Mar 2024 | SALE | AbbVie Inc. | 26,110 | 178.85 USD | |
| 18 Mar 2024 | SALE | AbbVie Inc. | 5,099 | 179.03 USD | |
| 18 Mar 2024 | EXERCISE | AbbVie Inc. | 26,110 | 61.36 USD | deriv |
| 28 Feb 2024 | TAX_WITHHOLDING | AbbVie Inc. | 26,121 | 178.99 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 7,840 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 8,810 | 0.00 USD | |
| 15 Feb 2024 | GRANT_AWARD | AbbVie Inc. | 33,042 | 0.00 USD |